Carisma Therapeutics, Inc.
US ˙ NasdaqCM ˙ US14216R1014

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Daniel Lynch. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Daniel Lynch har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:SWTX / SpringWorks Therapeutics, Inc. Director 0
US:TSVT / 2seventy bio, Inc. Director 21.053
US:BLUE / bluebird bio, Inc. Director 0
US:OMEG / Omega Alpha SPAC - Class A Director 35.000
US:BPMC / Blueprint Medicines Corporation Director 4.500
US:TBIO / Telesis Bio, Inc. Director 18.900
US:SURF / Surface Oncology Inc Director 12.000
US:SESN / Sesen Bio Inc. Director 52.500
US:BIND / BIND Therapeutics, Inc. Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Daniel Lynch. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb CARM / Carisma Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CARM / Carisma Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CARM / Carisma Therapeutics, Inc. Insider Trades
Insidersalg CARM / Carisma Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CARM / Carisma Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CARM / Carisma Therapeutics, Inc. Insider Trades
Insiderkøb TBIO / Telesis Bio, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CARM / Carisma Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TBIO / Telesis Bio, Inc. Insider Trades
Insidersalg TBIO / Telesis Bio, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CARM / Carisma Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TBIO / Telesis Bio, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Daniel Lynch som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-07-02 2025-07-01 4 SWTX SpringWorks Therapeutics, Inc.
Common Stock
D - Sale to Issuer -93.004 0 -100,00
2025-05-15 2025-05-14 4 SWTX SpringWorks Therapeutics, Inc.
Common Stock
A - Award 10.060 93.004 12,13
2025-02-24 2025-02-20 4 SWTX SpringWorks Therapeutics, Inc.
Common Stock
S - Sale X -3.582 82.944 -4,14 61,24 -219.349 5.079.192
2025-02-24 2025-02-20 4 SWTX SpringWorks Therapeutics, Inc.
Common Stock
S - Sale X -44.018 86.526 -33,72 60,14 -2.647.185 5.203.561
2025-02-19 2025-02-14 4 SWTX SpringWorks Therapeutics, Inc.
Common Stock
S - Sale X -400 130.544 -0,31 60,00 -24.000 7.832.640
2025-02-12 2025-02-10 4 SWTX SpringWorks Therapeutics, Inc.
Common Stock
S - Sale X -65.600 130.944 -33,38 55,51 -3.641.751 7.269.291
2025-02-12 2025-02-10 4 SWTX SpringWorks Therapeutics, Inc.
Common Stock
S - Sale X -39.634 196.544 -16,78 54,88 -2.175.047 10.786.001
2025-02-12 2025-02-10 4 SWTX SpringWorks Therapeutics, Inc.
Common Stock
S - Sale X -69.766 236.178 -22,80 53,23 -3.713.553 12.571.448
2024-05-17 2024-05-16 4 SWTX SpringWorks Therapeutics, Inc.
Common Stock
A - Award 4.095 305.944 1,36
2023-06-15 2023-06-13 4 TSVT 2seventy bio, Inc.
Common Stock
A - Award 8.400 21.053 66,39
2023-05-25 2023-05-24 4 SWTX SpringWorks Therapeutics, Inc.
Common Stock
A - Award 4.648 301.849 1,56
2022-06-09 2022-06-08 4 TSVT 2seventy bio, Inc.
Common Stock
A - Award 7.200 12.653 132,04
2022-05-20 2022-05-19 4 SWTX SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 15.318 15.318
2022-05-20 2022-05-19 4 SWTX SpringWorks Therapeutics, Inc.
Common Stock
A - Award 4.818 297.201 1,65
2021-11-17 2021-11-11 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
J - Other -7.000 0 -100,00
2021-11-17 2021-11-11 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
J - Other -4.200 4.135 -50,39
2021-11-17 2021-11-11 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
J - Other -5.600 5.513 -50,39
2021-11-17 2021-11-11 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
J - Other -5.600 5.513 -50,39
2021-11-17 2021-11-11 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
J - Other -5.600 5.513 -50,39
2021-11-17 2021-11-11 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
J - Other -5.600 5.513 -50,39
2021-11-17 2021-11-11 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
J - Other -10.500 10.337 -50,39
2021-11-17 2021-11-11 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
J - Other -10.500 10.337 -50,39
2021-11-17 2021-11-11 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
J - Other -23.342 22.981 -50,39
2021-11-17 2021-11-11 4 BLUE bluebird bio, Inc.
Common Stock
J - Other 0 7.959 0,00
2021-11-16 2021-11-11 4 TSVT 2seventy bio, Inc.
Stock Option (right to buy)
A - Award 4.507 4.507
2021-11-16 2021-11-11 4 TSVT 2seventy bio, Inc.
Stock Option (right to buy)
A - Award 1.378 1.378
2021-11-16 2021-11-11 4 TSVT 2seventy bio, Inc.
Stock Option (right to buy)
A - Award 1.837 1.837
2021-11-16 2021-11-11 4 TSVT 2seventy bio, Inc.
Stock Option (right to buy)
A - Award 1.837 1.837
2021-11-16 2021-11-11 4 TSVT 2seventy bio, Inc.
Stock Option (right to buy)
A - Award 1.837 1.837
2021-11-16 2021-11-11 4 TSVT 2seventy bio, Inc.
Stock Option (right to buy)
A - Award 1.837 1.837
2021-11-16 2021-11-11 4 TSVT 2seventy bio, Inc.
Stock Option (right to buy)
A - Award 3.445 3.445
2021-11-16 2021-11-11 4 TSVT 2seventy bio, Inc.
Stock Option (right to buy)
A - Award 3.445 3.445
2021-11-16 2021-11-11 4 TSVT 2seventy bio, Inc.
Stock Option (right to buy)
A - Award 7.660 7.660
2021-11-16 2021-11-11 4 TSVT 2seventy bio, Inc.
Common Stock
A - Award 2.803 5.453 105,77
2021-06-17 2021-06-15 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
A - Award 7.000 7.000
2021-06-17 2021-06-15 4 BLUE bluebird bio, Inc.
Common Stock
A - Award 4.353 12.312 54,69
2021-05-21 2021-05-20 4 SWTX SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 6.998 6.998
2021-05-21 2021-05-20 4 SWTX SpringWorks Therapeutics, Inc.
Common Stock
A - Award 1.106 292.383 0,38
2021-02-11 2020-12-08 5 SWTX SpringWorks Therapeutics, Inc.
Common Stock
G - Gift -100.000 459.577 -17,87
2021-01-06 3 OMEG Omega Alpha SPAC
Class B Ordinary Shares
35.000
2020-06-26 2020-06-24 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy)
A - Award 4.500 4.500
2020-06-26 2020-06-24 4 BPMC Blueprint Medicines Corp
Common Stock
A - Award 2.250 127.904 1,79
2020-06-23 2020-06-19 4 BPMC Blueprint Medicines Corp
Restricted Stock Units
M - Exercise -1.312 0 -100,00
2020-06-23 2020-06-19 4 BPMC Blueprint Medicines Corp
Common Stock
M - Exercise 1.312 125.654 1,06
2020-06-22 2020-06-18 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
A - Award 4.200 4.200
2020-06-22 2020-06-18 4 BLUE bluebird bio, Inc.
Common Stock
A - Award 2.100 7.959 35,84
2020-06-22 2020-06-18 4 BLUE bluebird bio, Inc.
Common Stock
A - Award 259 5.859 4,62
2020-06-17 2020-06-16 4 TBIO Translate Bio, Inc.
Stock Option (right to buy)
A - Award 18.900 18.900
2020-06-12 2020-06-10 4 SURF Surface Oncology, Inc.
Stock Option (Right to Buy)
A - Award 12.000 12.000
2020-05-22 2020-05-20 4 SWTX SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 7.464 7.464
2020-04-07 2020-04-03 4 BPMC Blueprint Medicines Corp
Common Stock
G - Gift -50.000 124.342 -28,68
2019-09-16 2019-09-12 4 SWTX SpringWorks Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 29.983 29.983
2019-09-12 3 SWTX SpringWorks Therapeutics, Inc.
Common Stock
782.554
2019-09-12 3 SWTX SpringWorks Therapeutics, Inc.
Common Stock
782.554
2019-09-12 3 SWTX SpringWorks Therapeutics, Inc.
Common Stock
782.554
2019-06-21 2019-06-19 4 SESN Sesen Bio, Inc.
Stock Option
A - Award 52.500 52.500
2019-06-20 2019-06-19 4 BPMC Blueprint Medicines Corp
Restricted Stock Units
A - Award 1.312 1.312
2019-06-20 2019-06-19 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy)
A - Award 4.875 4.875
2019-06-19 2019-06-18 4 TBIO Translate Bio, Inc.
Stock Option (right to buy)
A - Award 18.900 18.900
2019-06-10 2019-06-06 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
A - Award 5.600 5.600
2019-06-10 2019-06-06 4 BLUE bluebird bio, Inc.
Common Stock
A - Award 1.400 5.600 33,33
2019-06-06 2019-06-05 4 SURF Surface Oncology, Inc.
Stock Option (Right to Buy)
A - Award 12.100 12.100
2018-06-27 3 TBIO Translate Bio, Inc.
Common Stock
643.650
2018-06-27 3 TBIO Translate Bio, Inc.
Common Stock
643.650
2018-06-27 3 TBIO Translate Bio, Inc.
Common Stock
643.650
2018-06-25 2018-06-21 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy)
A - Award 7.500 29.318 34,38
2018-06-22 2018-06-20 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
A - Award 5.600 5.600
2018-06-22 2018-06-20 4 BLUE bluebird bio, Inc.
Common Stock
A - Award 1.400 4.200 50,00
2018-06-14 2018-06-12 4 SESN Sesen Bio, Inc.
Stock Option
A - Award 52.500 52.500
2018-02-16 2018-02-14 4 BPMC Blueprint Medicines Corp
Common Stock
S - Sale X -12.500 174.342 -6,69 80,42 -1.005.250 14.020.584
2018-02-14 2018-02-12 4 BPMC Blueprint Medicines Corp
Common Stock
S - Sale X -3.996 186.842 -2,09 73,27 -292.787 13.689.913
2018-02-14 2018-02-12 4 BPMC Blueprint Medicines Corp
Common Stock
S - Sale X -3.748 190.838 -1,93 74,31 -278.514 14.181.172
2018-02-14 2018-02-12 4 BPMC Blueprint Medicines Corp
Common Stock
S - Sale X -5.636 194.586 -2,81 75,15 -423.545 14.623.138
2018-02-14 2018-02-12 4 BPMC Blueprint Medicines Corp
Common Stock
S - Sale X -2.590 200.222 -1,28 75,96 -196.736 15.208.863
2018-02-14 2018-02-12 4 BPMC Blueprint Medicines Corp
Common Stock
S - Sale X -1.530 202.812 -0,75 77,18 -118.085 15.653.030
2017-11-17 2017-11-15 4 BPMC Blueprint Medicines Corp
Common Stock
S - Sale X -1.200 204.342 -0,58 62,59 -75.108 12.789.766
2017-11-17 2017-11-15 4 BPMC Blueprint Medicines Corp
Common Stock
S - Sale X -2.200 205.542 -1,06 63,25 -139.150 13.000.532
2017-11-17 2017-11-15 4 BPMC Blueprint Medicines Corp
Common Stock
S - Sale X -1.600 207.742 -0,76 64,15 -102.640 13.326.649
2017-09-20 2017-09-18 4 BPMC Blueprint Medicines Corp
Common Stock
S - Sale X -2.500 209.342 -1,18 60,00 -150.000 12.560.520
2017-09-05 2017-08-31 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -500 23.342 -2,10
2017-09-05 2017-08-31 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -500 2.800 -15,15 120,00 -60.000 336.000
2017-09-05 2017-08-31 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 500 3.300 17,86 5,50 2.750 18.151
2017-07-07 2017-07-05 4 BPMC Blueprint Medicines Corp
Common Stock
S - Sale X -7.500 211.842 -3,42 55,06 -412.950 11.664.021
2017-06-30 2017-06-28 4 BPMC Blueprint Medicines Corp
Common Stock
S - Sale X -3.125 219.342 -1,40 49,09 -153.406 10.767.499
2017-06-30 2017-06-28 4 BPMC Blueprint Medicines Corp
Common Stock
S - Sale X -21.474 222.467 -8,80 50,12 -1.076.277 11.150.046
2017-06-30 2017-06-28 4 BPMC Blueprint Medicines Corp
Common Stock
S - Sale X -7.901 243.941 -3,14 51,17 -404.294 12.482.461
2017-06-27 2017-06-23 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -1.992 23.842 -7,71
2017-06-27 2017-06-23 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -2.008 0 -100,00
2017-06-27 2017-06-23 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -800 2.800 -22,22 110,48 -88.385 309.348
2017-06-27 2017-06-23 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -1.000 3.600 -21,74 109,74 -109.740 395.064
2017-06-27 2017-06-23 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -2.200 4.600 -32,35 108,29 -238.237 498.132
2017-06-27 2017-06-23 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 1.992 6.800 41,43 5,50 10.957 37.403
2017-06-27 2017-06-23 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 2.008 4.808 71,71 2,09 4.189 10.031
2017-06-23 2017-06-21 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy)
A - Award 10.909 21.818 100,00
2017-06-22 2017-06-20 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -2.500 2.008 -55,46
2017-06-22 2017-06-20 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -2.500 2.800 -47,17 120,03 -300.070 336.078
2017-06-22 2017-06-20 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 2.500 5.300 89,29 2,09 5.216 11.058
2017-06-12 2017-06-08 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -2.500 4.508 -35,67
2017-06-12 2017-06-08 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
A - Award 5.600 5.600
2017-06-12 2017-06-08 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -2.500 2.800 -47,17 110,20 -275.488 308.546
2017-06-12 2017-06-08 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 2.500 5.300 89,29 2,09 5.216 11.058
2017-06-12 2017-06-08 4 BLUE bluebird bio, Inc.
Common Stock
A - Award 1.400 2.800 100,00
2017-06-08 2017-06-06 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -2.263 7.008 -24,41
2017-06-08 2017-06-06 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -2.263 1.400 -61,78 100,14 -226.622 140.199
2017-06-08 2017-06-06 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 2.263 3.663 161,64 2,09 4.722 7.642
2017-06-07 2017-06-05 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -1.000 9.271 -9,74
2017-06-07 2017-06-05 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -1.000 1.400 -41,67 90,00 -90.002 126.003
2017-06-07 2017-06-05 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 1.000 2.400 71,43 2,09 2.086 5.007
2017-05-30 2017-05-25 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -2.000 10.271 -16,30
2017-05-30 2017-05-25 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -1.000 1.400 -41,67 80,00 -80.001 112.002
2017-05-30 2017-05-25 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -1.000 2.400 -29,41 80,00 -80.000 192.000
2017-05-30 2017-05-25 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 2.000 3.400 142,86 2,09 4.173 7.094
2017-05-23 2017-05-19 4 EBIO Eleven Biotherapeutics, Inc.
Stock Option
A - Award 8.072 8.072
2017-05-01 2017-04-27 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -1.000 12.271 -7,54
2017-05-01 2017-04-27 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -1.000 1.400 -41,67 90,01 -90.010 126.014
2017-05-01 2017-04-27 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 1.000 2.400 71,43 2,09 2.086 5.007
2017-04-27 2017-04-25 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -2.000 13.271 -13,10
2017-04-27 2017-04-25 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -2.000 1.400 -58,82 86,75 -173.500 121.450
2017-04-27 2017-04-25 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 2.000 3.400 142,86 2,09 4.173 7.094
2017-03-28 2017-03-27 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -1.000 15.271 -6,15
2017-03-28 2017-03-27 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -1.000 1.400 -41,67 90,00 -90.000 126.000
2017-03-28 2017-03-27 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 1.000 2.400 71,43 2,09 2.086 5.007
2017-03-28 2017-03-24 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -2.000 16.271 -10,95
2017-03-28 2017-03-24 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -300 1.400 -17,65 87,63 -26.290 122.687
2017-03-28 2017-03-24 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -1.700 1.700 -50,00 87,10 -148.067 148.067
2017-03-28 2017-03-24 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 2.000 3.400 142,86 2,09 4.173 7.094
2017-03-20 2017-03-16 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -237 18.271 -1,28
2017-03-20 2017-03-16 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -237 1.400 -14,48 100,07 -23.718 140.104
2017-03-20 2017-03-16 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 237 1.637 16,93 2,09 494 3.415
2017-03-16 2017-03-14 4 BPMC Blueprint Medicines Corp
Common Stock
S - Sale X -7.500 250.119 -2,91 40,12 -300.900 10.034.774
2017-03-03 2017-03-01 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -2.000 18.508 -9,75
2017-03-03 2017-03-01 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -2.000 1.400 -58,82 90,32 -180.636 126.445
2017-03-03 2017-03-01 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 2.000 3.400 142,86 2,09 4.173 7.094
2017-02-28 2017-02-24 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -2.000 20.508 -8,89
2017-02-28 2017-02-24 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -1.000 1.400 -41,67 80,00 -80.000 112.000
2017-02-28 2017-02-24 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -1.000 2.400 -29,41 77,36 -77.365 185.676
2017-02-28 2017-02-24 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 2.000 3.400 142,86 2,09 4.173 7.094
2017-02-17 2017-02-15 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -150 22.508 -0,66
2017-02-17 2017-02-15 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -150 1.400 -9,68 80,22 -12.034 112.313
2017-02-17 2017-02-15 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 150 1.550 10,71 2,09 313 3.234
2017-02-16 2017-02-14 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -850 22.658 -3,62
2017-02-16 2017-02-14 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -850 1.400 -37,78 80,01 -68.011 112.018
2017-02-16 2017-02-14 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 850 2.250 60,71 2,09 1.773 4.694
2017-01-31 2017-01-27 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -1.000 23.508 -4,08
2017-01-31 2017-01-27 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -1.000 1.400 -41,67 70,09 -70.092 98.129
2017-01-31 2017-01-27 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 1.000 2.400 71,43 2,09 2.086 5.007
2016-12-05 2016-12-01 4 BPMC Blueprint Medicines Corp
Common Stock
S - Sale X -200 255.694 -0,08 30,02 -6.004 7.675.934
2016-11-03 2016-11-01 4 BPMC Blueprint Medicines Corp
Common Stock
S - Sale X -1.700 255.894 -0,66 30,04 -51.068 7.687.056
2016-10-17 2016-10-13 4 BPMC Blueprint Medicines Corp
Common Stock
S - Sale X -21.800 257.594 -7,80 30,02 -654.436 7.732.972
2016-08-30 2016-08-26 4 BIND DNIB UNWIND, INC.
Employee Stock Option (Right to Buy)
M - Exercise -20.000 0 -100,00
2016-08-30 2016-08-26 4 BIND DNIB UNWIND, INC.
Common Stock
M - Exercise 20.000 20.000 0,44 8.800 8.800
2016-06-27 2016-06-23 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy)
A - Award 10.909 10.909
2016-06-22 2016-06-21 4 BIND BIND Therapeutics, Inc
Employee Stock Option (Right to Buy)
A - Award 20.000 20.000
2016-06-10 2016-06-08 4 EBIO Eleven Biotherapeutics, Inc.
Stock Option
A - Award 8.072 8.072
2016-06-03 2016-06-02 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
A - Award -5.600 5.600 -50,00
2016-06-03 2016-06-02 4 BLUE bluebird bio, Inc.
Common Stock
A - Award 1.400 1.400
2015-12-02 2015-11-18 4 BPMC Blueprint Medicines Corp
Common Stock
J - Other 2.517 275.244 0,92
2015-10-07 2015-10-05 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -3.000 24.508 -10,91
2015-10-07 2015-10-05 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -600 0 -100,00 101,15 -60.690
2015-10-07 2015-10-05 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -2.400 600 -80,00 100,23 -240.552 60.138
2015-10-07 2015-10-05 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 3.000 3.000 2,09 6.259 6.259
2015-09-21 2015-09-17 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -1.500 27.508 -5,17
2015-09-21 2015-09-17 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -1.500 0 -100,00 140,06 -210.088
2015-09-21 2015-09-17 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 1.500 1.500 2,09 3.130 3.130
2015-09-10 2015-09-08 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -7.000 29.008 -19,44
2015-09-10 2015-09-08 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -2.050 0 -100,00 134,46 -275.652
2015-09-10 2015-09-08 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -1.300 2.050 -38,81 133,64 -173.737 273.970
2015-09-10 2015-09-08 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -600 3.350 -15,19 132,22 -79.331 442.931
2015-09-10 2015-09-08 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -2.550 3.950 -39,23 131,45 -335.194 519.222
2015-09-10 2015-09-08 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -500 6.500 -7,14 130,68 -65.340 849.414
2015-09-10 2015-09-08 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 7.000 7.000 2,09 14.605 14.605
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -29.500 36.008 -45,03
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -63 0 -100,00 154,59 -9.739
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -300 63 -82,64 153,83 -46.149 9.691
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -21 363 -5,47 153,66 -3.227 55.779
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -369 384 -49,00 151,95 -56.070 58.349
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -223 753 -22,85 151,94 -33.882 114.407
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -331 976 -25,33 151,08 -50.007 147.454
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -267 1.307 -16,96 150,21 -40.106 196.324
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -311 1.574 -16,50 149,31 -46.435 235.011
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -328 1.885 -14,82 148,46 -48.694 279.844
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -521 2.213 -19,06 147,00 -76.585 325.302
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -1.277 2.734 -31,84 145,36 -185.618 397.401
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -1.708 4.011 -29,87 144,47 -246.755 579.469
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -3.411 5.719 -37,36 143,28 -488.728 819.418
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -1.898 9.130 -17,21 142,45 -270.362 1.300.527
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -4.112 11.028 -27,16 141,16 -580.450 1.556.712
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -3.968 15.140 -20,77 140,25 -556.495 2.123.321
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -3.642 19.108 -16,01 136,33 -496.514 2.604.994
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -3.353 22.750 -12,85 135,40 -453.996 3.080.350
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -332 26.103 -1,26 134,20 -44.554 3.502.981
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -414 26.435 -1,54 133,08 -55.095 3.517.970
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -2.286 26.849 -7,85 132,29 -302.415 3.551.854
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -286 29.135 -0,97 131,12 -37.500 3.820.181
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale X -79 29.421 -0,27 130,56 -10.314 3.841.206
2015-08-11 2015-08-07 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 29.500 29.500 2,09 61.549 61.549
2015-06-18 2015-06-16 4 EBIO Eleven Biotherapeutics, Inc.
Stock Option
A - Award 8.072 8.072
2015-06-10 2015-06-09 4 BIND BIND Therapeutics, Inc
Employee Stock Option (Right to Buy)
A - Award 20.000 20.000
2015-06-08 2015-06-04 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
A - Award 10.500 10.500
2015-04-30 3 BPMC Blueprint Medicines Corp
Common Stock
545.454
2015-04-30 3 BPMC Blueprint Medicines Corp
Common Stock
545.454
2014-06-12 2014-06-11 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
A - Award 10.500 10.500
2014-05-29 2014-05-28 4 BIND BIND Therapeutics, Inc
Employee Stock Option (Right to Buy)
A - Award 20.000 20.000
2014-03-13 2014-03-11 4 BIND BIND Therapeutics, Inc
Employee Stock Option (Right to Buy)
A - Award 20.000 20.000
2014-02-13 2014-02-11 4 EBIO Eleven Biotherapeutics, Inc.
Common Stock (restricted)
A - Award 70.879 161.430 78,28
2013-09-27 2013-09-25 4 BIND BIND Therapeutics, Inc
Stock Option (right to buy)
A - Award 134.439 134.439
2013-09-27 2013-09-25 4 BIND BIND Therapeutics, Inc
Stock Option (right to buy)
A - Award 3.057 3.057
2013-09-27 2013-09-25 4 BIND BIND Therapeutics, Inc
Stock Option (right to buy)
A - Award 69.880 69.880
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)